China expands Beinao No.1 brain chip trials to 13 patients

The Chinese Institute for Brain Research (CIBR) and NeuCyber NeuroTech are rapidly advancing their brain chip project, Beinao No.1, aiming to implant it in 13 patients by the end of the year, potentially outpacing Elon Musk's Neuralink in patient data collection. The semi-invasive wireless brain chip has already been implanted in three patients, with plans for a larger clinical trial involving around 50 patients next year pending regulatory approval. This initiative highlights China's commitment to catching up with global leaders in brain-computer interface (BCI) technology, with U.S. company Synchron currently leading with 10 patients. The Beinao No.1 chip has demonstrated capabilities, enabling patients to control robotic arms and communicate through thought, showcasing significant potential for rehabilitation in individuals with paralysis. Meanwhile, industry policies discussed at the Zhongguancun Forum are set to enhance BCI research and development in China, including a fast-track approval process for medical devices. This ambitious project signifies a pivotal moment for BCI technology, as it may redefine patient care and technological competition globally.